Altre lingue PaxMedica, Inc.

Azioni

PXMD

US70424C2035

Mercato chiuso - OTC Markets Altri mercati azionari 21:18:19 05/07/2024			Variaz. 5gg	Var. 1 gen.
0,25 ^USD	-1,77%		+14,89%	-66,97%

13/05	PaxMedica, Inc. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
23/04	Paxmedica, Inc. risponde alla richiesta urgente di suramina per via endovenosa e si impegna a fornire l'accesso immediato a PAX-101	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101	15/05
PaxMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13/05
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy	07/05
PaxMedica, Inc.(NasdaqCM:PXMD) dropped from S&P TMI Index	06/05
PaxMedica, Inc.(NasdaqCM:PXMD) dropped from NASDAQ Composite Index	01/05
PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast	26/04
Paxmedica, Inc. Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101	23/04
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101	23/04
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness	16/04
PaxMedica, Inc. Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness	16/04
Sector Update: Health Care Stocks Slipping Late Afternoon	12/04
Top Midday Gainers	12/04
Major US Banks' Lower Earnings Drag Down Exchange-Traded Funds, Equity Futures Pre-Bell Friday	12/04
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission	11/04
PaxMedica, Inc. Achieves Key Milestone in the Development of Pax-101 and Provides Update on Potential NDA Submission	11/04
PaxMedica : Certificate of Incorporation/Bylaws - Form 8-K	22/03
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments	13/03
PaxMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	11/03
Certain Warrants of PaxMedica, Inc. are subject to a Lock-Up Agreement Ending on 19-FEB-2024.	19/02
Certain Common Stock of PaxMedica, Inc. are subject to a Lock-Up Agreement Ending on 19-FEB-2024.	19/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue PaxMedica, Inc.

Azioni

PXMD

US70424C2035

Altre lingue

Filtri